A growing body of evidence in recent years points to a connection between hearing loss and dementia later in life. In a new ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...

A new machine-learning approach for prostate-specific membrane antigen (PSMA) treatment of metastatic castration-resistant prostate cancer (mCRPC) could estimate radiation dose to tumors and healthy ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer treatment is failing weeks earlier than current tests, according to a UK-wide study led by UCL researchers ...

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment Screening for prostate cancer with a blood test can save men’s lives, but the “absolute ...

A previous trial involving patients with metastatic prostate cancer that was resistant to androgen pathway modulation (formerly referred to as castration-resistant) showed that adding talazoparib ...

Does prostate cancer screening save lives? The Cochrane, an influential group renowned for its gold-standard medical reviews, has previously addressed that question twice, and twice the answer was ‘no ...

Partnering with University of Michigan Health represents an important step in bringing Unfold AI to leading cancer centers ...

Researchers with the James P. Allison Institute at The University of Texas MD Anderson Cancer Center have discovered a new ...